Pediatric developmental syndromes present with systemic, complex, and often overlapping clinical features that are not infrequently a consequence of Mendelian inheritance of mutations in genes involved in DNA methylation, establishment of histone modifications, and chromatin remodeling (the ''epigenetic machinery''). The mechanistic cross-talk between histone modification and DNA methylation suggests that these syndromes might be expected to display specific DNA methylation signatures that are a reflection of those primary errors associated with chromatin dysregulation. Given the interrelated functions of these chromatin regulatory proteins, we sought to identify DNA methylation epi-signatures that could provide syndrome-specific biomarkers to complement standard clinical diagnostics. In the present study, we examined peripheral blood samples from a large cohort of individuals encompassing 14 Mendelian disorders displaying mutations in the genes encoding proteins of the epigenetic machinery. We demonstrated that specific but partially overlapping DNA methylation signatures are associated with many of these conditions. The degree of overlap among these epi-signatures is minimal, further suggesting that, consistent with the initial event, the downstream changes are unique to every syndrome. In addition, by combining these epi-signatures, we have demonstrated that a machine learning tool can be built to concurrently screen for multiple syndromes with high sensitivity and specificity, and we highlight the utility of this tool in solving ambiguous case subjects presenting with variants of unknown significance, along with its ability to generate accurate predictions for subjects presenting with the overlapping clinical and molecular features associated with the disruption of the epigenetic machinery.
Introduction
Genes encoding the epigenetic protein machinery that read, write, and erase post-translational signals on DNA and histones and remodel chromatin are implicated in a wide range of constitutional neurodevelopmental disorders. [1] [2] [3] The pathogenesis of such disorders is likely caused by the downstream events orchestrated by the primary functional defect in these proteins of the so-called epigenetic machinery. While the number of developmental and cancer-related conditions for which a DNA methylation epi-signature has been reported is increasing, the extent of overlap or distinction of these epi-signatures is not clear. Clinical overlap is a common finding in the diseases that result from such defects, and it is postulated that mechanistic overlap could be a basis for such phenotypic similarity. This is further acknowledged by noting that all of the proteins associated with these conditions regulate the epigenome through complex interactions with each other. Hence, the question has been raised as to how accurately one can use these epi-signatures as a tool in the molecular diagnosis of these conditions. 9,10 This is particularly important in the context of utilizing these epi-signatures as functional evidence to classify variants of uncertain clinical significance.
In the present study, we try to address these questions by concurrently examining 14 Mendelian conditions that result from direct or indirect disruptions of the proteins involved in the regulation of the epigenome. These conditions (see Table 1 In this study, we have identified DNA methylation profiles in peripheral blood samples from a large cohort of individuals who carry mutations in the associated candidate genes responsible for their respective developmental syndromes, including previously unreported signatures in cohorts for GTPTS and SBBYSS (KAT6B) and Claes-Jensen syndrome (KDM5C). We have also examined the degree of positional overlap between these epi-signatures and have evaluated whether a single classification tool, built on the combined epi-signatures of these conditions, can generate accurate predictions for subjects presenting with the overlapping clinical and molecular features associated with mutations in these genes that play an essential role in the epigenetic machinery. 
